Merck & Co’s CEO has doubts over fast COVID-19 vaccine developmentMerck & Co’s CEO Kenneth Frazier has warned that the many COVID-19 vaccines under development are not guaranteed Share XMerck & Co’s CEO has doubts over fast COVID-19 vaccine developmenthttps://pharmaphorum.com/news/merck-cos-ceo-cast-doubts-about-fast-covid-19-vaccine-development/
FDA to fast track development of two COVID-19 vaccines from Pfizer and BioNTechTwo of Pfizer and BioNTech’s potential COVID-19 vaccines have been granted Fast Track status by the FDA, a Share XFDA to fast track development of two COVID-19 vaccines from Pfizer and BioNTechhttps://pharmaphorum.com/news/fda-to-fast-track-development-of-two-covid-19-vaccines-from-pfizer-and-biontech/
Sanofi and Translate Bio expand mRNA vaccine agreementSanofi’s Pasteur vaccines unit and Translate Bio have expanded a collaboration to develop mRNA-based vaccines across all infectious Share XSanofi and Translate Bio expand mRNA vaccine agreementhttps://pharmaphorum.com/news/sanofi-and-translate-bio-expand-mrna-vaccine-agreement/
GSK begins COVID-19 vaccine trial with CloverGlaxoSmithKline has begun a COVID-19 clinical trial with China’s Clover Biopharmaceuticals, combining its booster with the biotech’s early-stage vaccine. GSK said Share XGSK begins COVID-19 vaccine trial with Cloverhttps://pharmaphorum.com/news/gsk-begins-covid-19-vaccine-trial-with-clover/
J&J brings forward start of COVID-19 vaccine trial to next monthJohnson & Johnson has announced it has brought forward the start of its COVID-19 vaccine by around two Share XJ&J brings forward start of COVID-19 vaccine trial to next monthhttps://pharmaphorum.com/news/jj/
AZ makes plans to supply 2 billion doses of COVID-19 vaccineAstraZeneca has announced new plans to increase the global supply of Oxford University’s COVID-19 vaccine to more than Share XAZ makes plans to supply 2 billion doses of COVID-19 vaccinehttps://pharmaphorum.com/news/az-makes-plans-to-supply-2-billion-doses-of-coronavirus-vaccine/
Oxford Biomedica signs COVID-19 vaccine supply deal with AZGene and cell therapy specialist Oxford Biomedica has signed a one-year agreement with AstraZeneca to manufacture the potential COVID-19 vaccine in Share XOxford Biomedica signs COVID-19 vaccine supply deal with AZhttps://pharmaphorum.com/news/oxford-biomedica-signs-covid-19-vaccine-supply-deal-with-az/
GSK to produce a billion doses of COVID-19 vaccine booster by 2021GlaxoSmithKline is to scale up production of its COVID-19 vaccine booster to a billion doses by 2021 to support development of Share XGSK to produce a billion doses of COVID-19 vaccine booster by 2021https://pharmaphorum.com/news/gsk-to-produce-a-billion-doses-of-covid-19-vaccine-booster-by-2021/
Merck & Co and IAVI join forces to develop COVID-19 vaccineMerck & Co has joined with the non-profit scientific research organisation, the International AIDS Vaccine Initiative (IAVI), to Share XMerck & Co and IAVI join forces to develop COVID-19 vaccinehttps://pharmaphorum.com/news/merck-co-and-iavi-join-forces-to-develop-covid-19-vaccine/
